Sean Nolan
2023
In 2023, Sean Nolan earned a total compensation of $1.5M as Chief Executive Officer and Director at Taysha Gene Therapies, a 20% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $324,000 |
---|---|
Option Awards | $597,184 |
Salary | $600,000 |
Other | $1,331 |
Total | $1,522,515 |
Nolan received $600K in salary, accounting for 39% of the total pay in 2023.
Nolan also received $324K in non-equity incentive plan, $597.2K in option awards and $1.3K in other compensation.
Rankings
In 2023, Sean Nolan's compensation ranked 780th out of 2,978 executives tracked by ExecPay. In other words, Nolan earned more than 73.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 780 | 74th |
Manufacturing | 452 | 72nd |
Chemicals And Allied Products | 310 | 66th |
Drugs | 303 | 65th |
Biological Products, Except Diagnostic Substances | 95 | 55th |
Nolan's colleagues
We found two more compensation records of executives who worked with Sean Nolan at Taysha Gene Therapies in 2023.